Singapore, Sept. 24 -- The University of Melbourne has joined the Structural Genomics Consortium (SGC) with the establishment of SGC-Melbourne, a new SGC Affiliated Site and the consortium's only site in Australasia.

SGC-Melbourne will enable Australian scientists to contribute directly to Target 2035, the SGC-led global mission to develop a pharmacological tool for every human protein by 2035.

Led by University of Melbourne Professor Megan Maher, an internationally acclaimed chemist, SGC-Melbourne will connect Australia's expertise in protein science, structural biology and chemical biology with the global SGC network, strengthening Australia's capacity to address rare and challenging diseases.

A key part of Target 2035 is to generate...